Dr. Anna Latorre, MD, PhD, is a clinical neuroscientist and Consultant Neurologist with a specialised focus on the neurophysiology of movement disorders and transcranial methods of cortical stimulation of the human brain. Her research centres on understanding the pathophysiological mechanisms of hyperkinetic movement disorders such as dystonia, myoclonus, and tremor. Utilising advanced electrophysiological methods, she also explores innovative therapeutic approaches and novel diagnostic methods. Following her medical training, Anna pursued a neurology residency at the University of Rome Sapienza under the mentorship of Prof. A. Berardelli. To deepen her expertise, she joined the Queen Square Institute of Neurology UCL, where she completed a PhD in neuroscience and a clinical/research fellowship under the guidance of Prof. K. Bhatia and Prof. J. Rothwell. Currently, Anna serves as an Honorary Associate Professor and Consultant Neurologist at Queen Square Institute of Neurology UCL, continuing her clinical and research work in movement disorders. Her clinical practice remains a cornerstone of her career, and her research is not only aimed at advancing the understanding of movement disorders but also at translating these findings into impactful clinical solutions. Anna has authored more than 100 peer-reviewed articles published in leading international journals, reflecting her significant contributions to the field. She holds prominent roles, including membership of the MDS Clinical Neurophysiology Study Group, where she chairs the Myoclonus subgroup. Additionally, Anna serves on the Editorial Board of Movement Disorders Clinical Practice Journal and collaborates extensively with world-renowned experts in brain stimulation.

Dr. Eugenia Ho, MD, MPH, is the Medical Director of Critical Care Neurology and Fetal-Neonatal Neurology at Children’s Hospital Los Angeles, where she also serves as an Attending Physician in the Division of Neurology. She is an Associate Professor of Neurology and Pediatrics at the Keck School of Medicine of USC. Dr. Ho earned her medical degree from Indiana University School of Medicine and her Master of Public Health from Harvard, followed by pediatric training at Loma Linda University Children’s Hospital and a child neurology residency at Boston Children’s Hospital of Harvard Medical School. She then completed fellowship training in pediatric stroke and neonatal neurology at Boston Children’s Hospital. Her clinical and academic focus lies in caring for neonates, infants, and children with acute neurological disorders. She leads the Neurocritical Care Consultation Service and the Fetal-Neonatal Neurology Program at CHLA, working within multidisciplinary teams to provide comprehensive evaluation and management of critically ill children. Board-certified in Pediatrics, Child Neurology, and Neurocritical Care, Dr. Ho also participates in clinical research aimed at mitigating the effects of brain injury and improving neurodevelopmental outcomes. She is an active member of the Pediatric Neurocritical Care Research Group, the Child Neurology Society, and the American Academy of Neurology, and she has been recognized with the American Academy of Neurology Clinical Research Training Fellowship.

Dr. Iva Stankovic MD, PhD is a consultant neurologist at the University Clinical Center of Serbia and Assistant Professor of Neurology at the Faculty of Medicine, University of Belgrade. She specializes in movement and neurodegenerative disorders, with a focus on Parkinson’s disease and multiple system atrophy. Dr. Stankovic has trained at the Medical University of Innsbruck under Prof. Gregor K. Wenning and has published extensively, with over 75 PubMed-indexed papers, five book chapters, an h-index of 28, and more than 2,500 citations. She serves on several international committees of the International Parkinson and Movement Disorder Society and the European Academy of Neurology, and is a member of the MSA Coalition Research Steering Council. Her research has been recognized with awards including the Young Investigator Award of the Otto Loewi Gesellschaft (2018) and multiple best paper recognitions in Movement Disorders journals.

Dr. Lis Kadastik-Eerme, MD, PhD, is a neurologist at the Neurology Clinic of Tartu University Hospital, Estonia, with a primary focus on movement disorders, particularly the diagnosis and treatment of Parkinson’s disease. She earned her PhD in 2019, researching Parkinson’s disease in Estonia, including its epidemiology, clinical characteristics, quality of life, and pharmacotherapy. Her current research explores early connections between idiopathic polyneuropathy and Parkinson’s disease. Since 2024, she serves as President of the Estonian Movement Disorders Society.

Dr. Niko Arzumanyan, MD is a neurosurgery senior resident at the University Clinic of Neurosurgery and Comprehensive Stroke Center of the Yerevan State Medical University after M. Heratsi. Since February 2022 he is doing a fellowship in Saint Ivan Rilsky hospital Neurosurgery Department in Bulgaria.

Dr. Quyen N. Luc, MD is the Assistant Medical Director of the Pediatric Movement Disorders Program and an Attending Physician in the Division of Neurology at Children’s Hospital Los Angeles. She also serves as an Assistant Professor of Neurology at the Keck School of Medicine of USC. Dr. Luc earned her medical degree from Vanderbilt University School of Medicine, completed her internship and residency at Los Angeles County/Harbor–UCLA Medical Center, and pursued fellowship training in Child Neurology and Pediatric Movement Disorders at Children’s Hospital Los Angeles. Her clinical interests focus on pediatric movement disorders, and she is board-certified in Neurology with special competence in Child Neurology by the American Board of Psychiatry and Neurology. Dr. Luc is a member of the Child Neurology Society, the International Child Neurology Congress, and the Movement Disorders Society.

Dr. Samson Khachatryan, MD, PhD is a neurologist, Chairman, Department of Neurology and Neurosurgery, National Institute of Health, Armenia, Neurology Advisor to Ministry of Health, Armenia, Director, “Somnus” Neurology Clinic, Armenia. After completing his neurology residency program at the Department of Neurology, Erebouni Medical Center (YSMU), Dr. Samson Khachatryan successfully defended his candidacy research work in 2008. He passed fellowships, observerships and trainings in the USA and Europe at different neurological clinics, e.g. New-York Cornell Medical Center (2006), Cleveland Clinic Foundation Neuroscience Institute (2006), EFNS Department-to-Department program at InselSpital Medical Center, Bern, Switzerland (2007), Innsbruck Medical University, Austria (2014), Lugano Regional Hospital Neurology Center, Switzerland (2014). Samson Khachatryan’s PhD project was dedicated to epilepsy and done at Armenian Republic Epilepsy Center (“Quantitative assessment of Quality of Life in Epilepsy”). In 2010 he founded “Somnus” Neurology Clinic (with Center for Sleep and Movement Disorders), where he runs scientific research in the frames of his doctoral thesis (Role of sleep disorders in epilepsy) and other projects together with extensive practical work. His interests include epilepsy\/EEG, sleep disorders, movement disorders, dementia, headache, chronic pain, etc. From July 2019 Dr. Samson Khachatryan became the Chairman of the newly reopened Department of Neurology and Neurosurgery at Armenian National Institute of Health. He helps shaping adult and pediatric neurology residency programs alongside with different length CME programs for practicing neurologists. Also, international scientific collaborations with UCL Institute of Neurology and Neurosurgery Department of Neurogenetics, ENIGMA-PD, and others are underway.

Dr. Talene Yacoubian, MD, PhD, is a professor of neurology and neurobiology, John A. and Ruth R. Jurenko endowed professorship in neurology. She has graduated magna cum laude with her a.b. in biochemical sciences from Harvard college. She holds an M.D. and Ph.D. in Neurobiology from Duke University School of Medicine in Durham, North Carolina. Dr. Yakoubian completed her Neurology Residency at Harvard Medical School’s Partners Neurology Residency Program (Massachusetts General Hospital and Brigham and Women’s Hospital) in Boston, MA. She then served as a Research and Clinical Fellow in Movement Disorders at Harvard Medical School/Massachusetts General Hospital before joining the UAB Neurology faculty. At UAB, Dr. Yacoubian divides her time between patient care, laboratory research, and training of future physician-scientists. She cares for patients with movement disorders at the Kirklin Clinic and directs a specialized clinic focused on ataxia. She is Co-Director of the UAB Medical Scientist Training Program. Her research is focused on understanding the mechanisms underlying neurodegeneration and testing proteins with neuroprotective potential in cellular and animal models of Parkinson’s disease. She is the Director of the Alabama Udall Clinical Core. Her research has been funded by the American Parkinson Disease Association, the Michael J. Fox Foundation, the Parkinson Association of Alabama, and the National Institutes of Health.

Dr. Vijay Vishwanath, MD, PhD, is an Attending Physician in the Division of Neurology at Children’s Hospital Los Angeles and an Assistant Professor of Clinical Neurology and Pediatrics at the Keck School of Medicine of USC. He earned his medical degree from Bangalore Medical College and Research Institute and a PhD in Neuroscience from the University of Utah, followed by residency training at the University of Tennessee College of Medicine and fellowship at the New York University School of Medicine. Board-certified in Child Neurology and Epilepsy, Dr. Vishwanath has clinical and academic interests in neurocutaneous disorders, including neurofibromatosis and tuberous sclerosis, as well as tic disorders such as Tourette syndrome. Before joining CHLA, he directed the Albany Medical Center Tic Disorder Clinic. He also has extensive experience treating pediatric epilepsy patients, ranging from common febrile seizures to complex, intractable syndromes, utilizing both newer anti-seizure medications and device-based therapies such as vagal nerve stimulation. Dr. Vishwanath is an active member of the Child Neurology Society, the American Epilepsy Society, and the American Academy of Neurology, and he was awarded the Dentinger Award in 2019 for excellence in resident education.

Dr. Yury Seliverstov, MD, PhD, is a neurologist and clinical researcher at the University Clinic of Ulm (Germany). His work focuses on movement disorders and neurodegenerative diseases, functional neurological disorders, and botulinum toxin therapy. He is actively involved in several clinical trials in Huntington disease and contributes to the observational studies Enroll-HD and HDClarity. Dr. Seliverstov serves on the Steering Committee of the MDS Pediatric Special Interest Group, is a member of the EAN Movement Disorder Scientific Panel, and serves on the Educational Committee of the Functional Neurological Disorder Society. He previously served two terms on the MDS-ES Educational Committee and co-directed the MDS-ES Affiliate & National Society Video Case Discussion Series.

Dr. Zaruhi Tavadyan, MD is a neurologist specializing in Parkinson’s disease and movement disorders. She is the Head of the Parkinson’s and Movement Disorders Center at the Somnus Sleep and Movement Disorders Clinic and serves as an Assistant Professor at the Department of Neurology and Neurosurgery of the National Institute of Health of Armenia. Dr. Tavadyan received her medical education at Yerevan State Medical University (General Medicine, Neurology) and later specialized in movement disorders, sleep medicine, and Deep Brain Stimulation through advanced trainings in Austria, the United Kingdom, Hungary, the Netherlands, and other countries. She is a member of several international professional organizations, including the International Parkinson’s and Movement Disorder Society, the European Huntington’s Disease Network, and serves as the Primary Investigator for the Global Parkinson’s Genetics Program (GP2) from Armenia. She is also involved in the Education Committee of the European Section of the International Parkinson’s and Movement Disorder Society. Her professional focus lies in the early diagnosis of movement disorders, the implementation of innovative therapies, and the advancement of international collaboration.